Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Hester Biosciences (HESTERBIO.NS) has a market cap of $0.18 billion USD. According to our data, Hester Biosciences is ranked No.7101 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $0.18 B |
-26.03%
|
| Dec 31, 2024 | $0.24 B |
64.98%
|
| Dec 29, 2023 | $0.14 B |
-18.25%
|
| Dec 30, 2022 | $0.18 B |
-28.92%
|
| Dec 31, 2021 | $0.25 B |
48.81%
|
| Dec 31, 2020 | $0.17 B |
18.34%
|
| Dec 31, 2019 | $0.14 B |
28.91%
|
| Dec 31, 2018 | $0.11 B |
-38.64%
|
| Dec 29, 2017 | $0.18 B |
160.92%
|
| Dec 30, 2016 | $68.60 M |
29.35%
|
| Dec 31, 2015 | $53.03 M |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Zoetis
ZTS
|
$66.32 B |
-0.000 M
|
USA
|
 Elanco
ELAN
|
$4.19 B |
-0.000 M
|
USA
|
 Phibro Animal Health
PAHC
|
$0.70 B |
0.349 B
|
USA
|
 IDEXX Laboratories
IDXX
|
$33.35 B |
0.001 M
|
USA
|
 Neogen
NEOG
|
$0.95 B |
0.000 M
|
USA
|
 PetIQ
PETQ
|
$0.93 B |
0.000 M
|
USA
|
| Market Cap | = | HESTERBIO.NS Stock Price | * | HESTERBIO.NS Shares Outstanding |
| = | $20.78 | * | 8.51 M | |
| = | $0.18 B |